SCHEMBL7981443

SCHEMBL7981443

COC1CCCN1S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.52
TSHR P16473 2/20 0.52
GAA P10253 2/20 0.51
HPGD P15428 1/20 0.51
L3MBTL1 Q9Y468 2/20 0.49
MCOLN3 Q8TDD5 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
ACHE P22303 1/20 0.49
ALDH1A1 P00352 4/20 0.49
POLB P06746 2/20 0.49
PKM P14618 2/20 0.49
HTT P42858 1/20 0.49
RAB9A P51151 2/20 0.48
MAPT P10636 2/20 0.47
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 2/20 0.47
MEN1 O00255 1/20 0.47
HSD17B10 Q99714 1/20 0.47
LMNA P02545 1/20 0.47
PAX8 Q06710 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6842733 0.95 PSEN1 (0.50) MAPK1TSHRGAAHPGDL3MBTL1
SCHEMBL28243001 0.87 TRPA1 (0.61) TSHRNPSR1ALDH1A1PKMMAPT
SCHEMBL27976150 0.87 HCRTR1 (0.50) ALDH1A1HTTMAPTLMNA
SCHEMBL27976149 0.87 HCRTR1 (0.50) ALDH1A1HTTMAPTLMNA
SCHEMBL28242970 0.87 TRPA1 (0.61) TSHRNPSR1ALDH1A1PKMMAPT
SCHEMBL27506312 0.83 NPSR1 (0.48) MAPK1TSHRGAAHPGDL3MBTL1
SCHEMBL7328060 0.83 GAA (0.53) MAPK1TSHRGAAHPGDL3MBTL1
SCHEMBL27758830 0.82 GHSR (0.50) TSHRALDH1A1HTTLMNA
SCHEMBL15013036 0.81 CASP3 (0.64) RAB9APAX8
SCHEMBL12169307 0.81 CASP3 (0.64) RAB9APAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6225306-B1 PYRROLO(1,2A)QUINOXALINES WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 2001-05-01 US disclosed
EP-0987266-A1 BIPHENYL DERIVATIVES AND MEDICINAL COMPOSITIONS Wakamoto Pharmaceutical Co., Ltd. (JP) 2000-03-22 EP disclosed